Panel Discussion: Realizing the Promise, Gaps & Platform Innovation for Precision Medicine at Scale from Global Technology Leaders
- Where do leading technology companies see the greatest unrealized promise and unmet need in precision medicine today, and which technology innovations are required to unlock meaningful clinical and commercial impact?
- How can AI-driven biomarker discovery, precision stratification, and patient-level digital twins be operationalized at scale, and what infrastructure, data strategies, and partnerships are required to make this a clinical reality?